Dual AntiPlatelet Therapies for Prevention of Periinterventional Embolic Events in TAVI
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.
Also called NCT03001960
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 200 participants
- Registry
-
NCT03001960
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Unknown status
Technical summary
Registry record NCT03001960. Randomized; double masking; primary purpose treatment. Start 2017-03 (registry gives no type); primary completion 2018-03 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Dual AntiPlatelet Therapies for Prevention of Periinterventional Embolic Events in TAVI
- Acronym
- DAPT-TAVI
- Condition
- Aortic Valve Stenosis
- Condition
- Intracranial Embolism
- Intervention (Drug)
- Preloading before TAVI
- Intervention (Drug)
- Postloading after TAVI
- Lead sponsor
- Charite University, Berlin, Germany
- Collaborator
- Prof. Dr. Jochen Fiebach, Center for Stroke Research Berlin (CSB), Charité - Universitaetsmedizin Berlin
Record details
- Record id
cardio:ct-nct03001960- Content hash
83f23e36c017f098ba704dec8e0405e5364574643ca255ccb08a738fae2c31c9